Novotech Sponsors Oncology Summit With eChina Health And Expert Panel On Drug Development Acceleration With Endpoints For ASCO 2023

Chicago, IL USA - Novotech, the leading Asia Pacific centred biotech CRO is sponsoring key oncology focused expert events for ASCO: a pre-ASCO Summit with eChina Health, and a webinar panel discussion on accelerating development of advanced therapies with Endpoints. 

Meet with the Novotech team at ASCO here

Novotech, which has more than 15 senior executives and oncology leaders attending ASCO, is sponsoring the eChina Health pre-ASCO China Summit and Dinner. The Summit brings together world leaders in oncology for a 1-day series of expert presentations.

Novotech CEO Dr. John Moller will give the welcome address, Novotech Chief Commercial Officer Barry Murphy will present during the session on “Bringing Transformational Medicines to Patients Worldwide” and Novotech Head of China Andy Liu is a panellist on the “Future of China Biopharmaceutical” session.

Session topics include:
•    Showcase Novel Breakthrough Therapies from China
•    Bringing Transformational Medicines to Patients Worldwide 
•    Future of China Biopharmaceutical
•    China Clinical Oncology Breakthrough
•    Global Clinical Oncology Breakthrough (by ASCO Breakthrough Organizing Committee)

Location: 320 S. Canal St. The Platform Conference Center Chicago
Date: June 1
Time: 1-8.30pm (Central Time)
Register here

The Novotech ASCO expert webinar panel in partnership with Endpoints is titled "How to accelerate development in novel & advanced oncology therapies — from the starting line.”